Maven VCTs invest a further GBP500,000 in GENinCode as company goes to IPO
Maven Capital Partners (Maven), has invested a further GBP500,000 in GENinCode, a genetic testing company specialising in the risk assessment and prediction of cardiovascular disease. This funding package comes as the company completes its IPO, raising an additional GBP17 million gross and listing on AIM with a market capitalisation of